The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Chiral pharmaceuticals: A review on their environmental occurrence and fate processes
Open accessAbstract
More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics, pharmacodynamics and toxicity. The advancement in separation and detection methods has made it possible to analyze trace amounts of chiral compounds in environmental media. As a result, interest on chiral analysis and evaluation of stereoselectivity in environmental occurrence, phase distribution and degradation of chiral pharmaceuticals has grown substantially in recent years. Here we review recent studies on the analysis, occurrence, and fate of chiral pharmaceuticals in engineered and natural environments. Monitoring studies have shown ubiquitous presence of chiral pharmaceuticals in wastewater, surface waters, sediments, and sludge, particularly β-receptor antagonists, analgesics, antifungals, and antidepressants. Selective sorption and microbial degradation have been demonstrated to result in enrichment of one enantiomer over the other. The changes in enantiomer composition may also be caused by biologically catalyzed chiral inversion. However, accurate evaluation of chiral pharmaceuticals as trace environmental pollutants is often hampered by the lack of identification of the stereoconfiguration of enantiomers. Furthermore, a systematic approach including occurrence, fate and transport in various environmental matrices is needed to minimize uncertainties in risk assessment of chiral pharmaceuticals as emerging environmental contaminants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmaceuticals and personal care products in the environment: agents of subtle change?
Daughton, C. G., & Ternes, T. A. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s6907 · Cited by 4,705
Occurrence, fate and effects of pharmaceutical substances in the environment- A review
Halling-Sørensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten Lützhøft, H. C., & Jørgensen, S. E. (1998) · Chemosphere · doi:10.1016/s0045-6535(97)00354-8 · Cited by 3,285
Kümmerer, K. (2009) · Journal of Environmental Management · doi:10.1016/j.jenvman.2009.01.023 · Cited by 1,474
Pal, A., Gin, K. Y.-H., Lin, A. Y.-C., & Reinhard, M. (2010) · Science of The Total Environment · doi:10.1016/j.scitotenv.2010.09.026 · Cited by 1,137
Pharmaceuticals in the environment : sources, fate, effects and risks
Kümmerer, K. (2008) · FreiDok plus (Universitätsbibliothek Freiburg) · Cited by 911
Pharmaceuticals in the Environment
Kümmerer, K. (2010) · Annual Review of Environment and Resources · doi:10.1146/annurev-environ-052809-161223 · Cited by 816
The use of X‐ray crystallography to determine absolute configuration
Flack, H. D., & Bernardinelli, G. (2008) · Chirality · doi:10.1002/chir.20473 · Cited by 707
Buser, H.-R., Poiger, T., & Müller, M. D. (1999) · Environmental Science & Technology · doi:10.1021/es981014w · Cited by 676
Effects of environmental pollutants on gut microbiota
Jin, Y., Wu, S., Zeng, Z., & Fu, Z. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2016.11.045 · Cited by 660
Putting chirality to work: the strategy of chiral switches
Agranat, I., Caner, H., & Caldwell, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd915 · Cited by 637
Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
Ari�ns, E. J. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541922 · Cited by 609
Chiral Toxicology: It's the Same Thing…Only Different
Smith, S. W. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp097 · Cited by 602
FDA'S policy statement for the development of new stereoisomeric drugs
(1992) · Chirality · doi:10.1002/chir.530040513 · Cited by 581
Sanderson, H. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00257-1 · Cited by 501
Chiral selection on inorganic crystalline surfaces
Hazen, R. M., & Sholl, D. S. (2003) · Nature Materials · doi:10.1038/nmat879 · Cited by 488 · cited 1×
“24 believe that chiral minerals and organic matter may serve as a chiral environment to potentially 505 foster stereoselectivity in sorption (Gámiz et al., 2016; Hazen and Sholl, 2003).”
Background(2009) · Wiley eBooks · doi:10.1002/9780470684122 · Cited by 475
Pharmacologically active compounds in the environment and their chirality
Kasprzyk-Hordern, B. (2010) · Chemical Society Reviews · doi:10.1039/c000408c · Cited by 456
Aquatic ecotoxicology of fluoxetine
Brooks, B. W., Foran, C. M., Richards, S. M., Weston, J., Turner, P. K., Stanley, J. K., Solomon, K. R., Slattery, M., & La Point, T. W. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00066-3 · Cited by 443
Hazen, R. M., Filley, T. R., & Goodfriend, G. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101085998 · Cited by 399
Martín, J., Camacho-Muñoz, D., Santos, J. L., Aparicio, I., & Alonso, E. (2012) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2012.04.068 · Cited by 399
Baker, D. R., & Kasprzyk-Hordern, B. (2013) · Science of The Total Environment · doi:10.1016/j.scitotenv.2013.03.043 · Cited by 379
Pharmaceuticals in the environment: scientific evidence of risks and its regulation
Küster, A., & Adler, N. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0587 · Cited by 370
Mineral surfaces, geochemical complexities, and the origins of life
Hazen, R. M., & Sverjensky, D. A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002162 · Cited by 344
He, Y., Wang, B., Dukor, R. K., & Nafié, L. A. (2011) · Applied Spectroscopy · doi:10.1366/11-06321 · Cited by 341
Huggett, D. B., Cook, J. C., Ericson, J. F., & Williams, R. T. (2003) · Human and Ecological Risk Assessment: An International Journal · doi:10.1080/714044797 · Cited by 327
Christou, A., Karaolia, P., Hapeshi, E., Michael, C., & Fatta-Kassinos, D. (2017) · Water Research · doi:10.1016/j.watres.2016.11.033 · Cited by 315
Wu, X., Conkle, J. L., Ernst, F., & Gan, J. (2014) · Environmental Science & Technology · doi:10.1021/es502868k · Cited by 293
Self-citationStanley, J. K., Ramirez, A. J., Chambliss, C. K., & Brooks, B. W. (2007) · Chemosphere · doi:10.1016/j.chemosphere.2007.04.080 · Cited by 255
メチル化DNA結合タンパク質MBD2はグルココルチコイド受容体のNGFI-A(egr-1)媒介転写活性化を促進する
Ian, C., Castleden, I. R., Shelley, E. B., Stephen, D., Sergiy, D., Josie, D., Tie-Yuan, Z., Moshe Szyf, A., & Michael, J. M. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · Cited by 255
Predicted critical environmental concentrations for 500 pharmaceuticals
Fick, J., Lindberg, R. H., Tysklind, M., & Larsson, D. G. J. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.08.025 · Cited by 243
Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems
Winkler, M. (2001) · Water Research · doi:10.1016/s0043-1354(01)00026-4 · Cited by 233
Biodegradability of pharmaceutical compounds in agricultural soils irrigated with treated wastewater
Grossberger, A., Hadar, Y., Borch, T., & Chefetz, B. (2014) · Environmental Pollution · doi:10.1016/j.envpol.2013.10.038 · Cited by 230
Subedi, B., & Kannan, K. (2015) · Science of The Total Environment · doi:10.1016/j.scitotenv.2015.01.098 · Cited by 228
Christen, V., Hickmann, S., Rechenberg, B., & Fent, K. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2009.11.021 · Cited by 222
Pharmaceuticals and Personal-Care Products in Plants
Bartrons, M., & Peñuelas, J. (2017) · Trends in Plant Science · doi:10.1016/j.tplants.2016.12.010 · Cited by 211
Fate of pharmaceuticals in rivers: Deriving a benchmark dataset at favorable attenuation conditions
Kunkel, U., & Radke, M. (2012) · Water Research · doi:10.1016/j.watres.2012.07.033 · Cited by 204
Attenuation of Wastewater-Derived Contaminants in an Effluent-Dominated River
Fono, L. J., Kolodziej, E. P., & Sedlak, D. L. (2006) · Environmental Science & Technology · doi:10.1021/es061308e · Cited by 203
Environmental fate processes and biochemical transformations of chiral emerging organic pollutants
Wong, C. S. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0424-3 · Cited by 199
Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
Mehvar, R., & Brocks, D. R. (2001) · PubMed · Cited by 185
Use of the Chiral Pharmaceutical Propranolol to Identify Sewage Discharges into Surface Waters
Fono, L. J., & Sedlak, D. L. (2005) · Environmental Science & Technology · doi:10.1021/es047965t · Cited by 178
Matamoros, V., Hijosa‐Valsero, M., & Bayona, J. M. (2009) · Chemosphere · doi:10.1016/j.chemosphere.2008.12.008 · Cited by 177
Ma, R., Wang, B., Lu, S., Zhang, Y., Yin, L., Huang, J., Deng, S., Wang, Y., & Yu, G. (2016) · Science of The Total Environment · doi:10.1016/j.scitotenv.2016.03.053 · Cited by 171
The psychoactive pollutant fluoxetine compromises antipredator behaviour in fish
Martin, J. M., Saaristo, M., Bertram, M. G., Lewis, P. J., Coggan, T. L., Clarke, B. O., & Wong, B. B. M. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2016.10.010 · Cited by 169
MacLeod, S. L., Sudhir, P., & Wong, C. S. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.09.010 · Cited by 159
Enantiomeric Profiling of Chiral Drugs in Wastewater and Receiving Waters
Kasprzyk‐Hordern, B., & Baker, D. R. (2011) · Environmental Science & Technology · doi:10.1021/es203113y · Cited by 158
Gómez, M. J., Gómez‐Ramos, M. D. M., Malato, O., Mezcúa, M., & Fernández‐Alba, A. R. (2010) · Journal of Chromatography A · doi:10.1016/j.chroma.2010.08.070 · Cited by 157
Nikolai, L. N., McClure, E. L., MacLeod, S. L., & Wong, C. S. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.07.033 · Cited by 156
Kasprzyk‐Hordern, B., Kondakal, V. V. R., & Baker, D. R. (2010) · Journal of Chromatography A · doi:10.1016/j.chroma.2010.04.073 · Cited by 154
Evans, S. E., Davies, P., Lubben, A., et al. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.03.039 · Cited by 137
Stereoselectivity of bioactive xenobiotics
Ariëns, E. J., Wuis, E. W., & Veringa, E. J. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90749-6 · Cited by 130
Pérez, S., & Barceló, . (2007) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2007.05.004 · Cited by 130
Recent progress of chiral stationary phases for separation of enantiomers in gas chromatography
Xie, S., & Yuan, L. (2016) · Journal of Separation Science · doi:10.1002/jssc.201600808 · Cited by 120
Stephens, P. J., Devlin, F. J., Gasparrini, F., et al. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo070302k · Cited by 116
LaLone, C. A., Villeneuve, D. L., Burgoon, L. D., Russom, C. L., Helgen, H. W., Berninger, J. P., Tietge, J. E., Severson, M. N., Cavallin, J. E., & Ankley, G. T. (2013) · Aquatic Toxicology · doi:10.1016/j.aquatox.2013.09.004 · Cited by 114
Chirality in bioactive agents and its pitfalls
Ariëns, E. J. (1986) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(86)90313-5 · Cited by 108
MacLeod, S. L., & Wong, C. S. (2009) · Water Research · doi:10.1016/j.watres.2009.09.056 · Cited by 107
Chiral Inversion of Drugs: Coincidence or Principle?
Wsól, V., Skálová, L., & Szotáková, B. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335360 · Cited by 105
Chiral pharmaceuticals in the environment
Ribeiro, A. R., Castro, P. M. L., & Tiritan, M. E. (2012) · Environmental Chemistry Letters · doi:10.1007/s10311-011-0352-0 · Cited by 100
López-Serna, R., Kasprzyk‐Hordern, B., Petrović, M., & Barceló, . (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-6900-7 · Cited by 99
Pharmaceuticals in the Environment – A Brief Summary
Kümmerer, K. (2008) · Springer eBooks · doi:10.1007/978-3-540-74664-5_1 · Cited by 95
Enantiomer profiling of high loads of amphetamine and MDMA in communal sewage: A Dutch perspective
Emke, E., Evans, S. I., Kasprzyk‐Hordern, B., & de Voogt, P. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.11.043 · Cited by 92
Bagnall, J. P., Evans, S. E., Wort, M. T., Lubben, A., & Kasprzyk‐Hordern, B. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.06.012 · Cited by 90
Castrignanò, E., Lubben, A., & Kasprzyk‐Hordern, B. (2016) · Journal of Chromatography A · doi:10.1016/j.chroma.2016.02.015 · Cited by 85
Environmental risk analysis and prioritization of pharmaceuticals in a developing world context
Mansour, F., Al‐Hindi, M., Saad, W., & Salam, D. A. (2016) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2016.03.023 · Cited by 83
Enantioselectivity of mass spectrometry: Challenges and promises
Awad, H., & El‐Aneed, A. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21379 · Cited by 82
Use of toxicity assays for enantiomeric discrimination of pharmaceutical substances
de Andrés, F., Castañeda, G., & Ríos, Á. (2008) · Chirality · doi:10.1002/chir.20675 · Cited by 82
Koba, O., Golovko, O., Kodešová, R., Klement, A., & Grabic, R. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.07.041 · Cited by 80
Stereoselective biodegradation of amphetamine and methamphetamine in river microcosms
Bagnall, J. P., Malia, L., Lubben, A., & Kasprzyk‐Hordern, B. (2013) · Water Research · doi:10.1016/j.watres.2013.06.057 · Cited by 78
Schaffer, M., Kröger, K. F., Nödler, K., Ayora, C., Carrera, J., Hernández, M. A. H., & Licha, T. (2015) · Water Research · doi:10.1016/j.watres.2015.02.010 · Cited by 76
Amorim, C. L., Moreira, I. S., Ribeiro, A. R., Santos, L. H. M. L. M., Delerue-Matos, C. M., Tiritan, M. E., & Castro, P. M. L. (2016) · International Biodeterioration & Biodegradation · doi:10.1016/j.ibiod.2016.09.009 · Cited by 76
Ribeiro, A. R., Santos, L. H. M. L. M., Maia, A. S., Delerue-Matos, C. M., Castro, P. M. L., & Tiritan, M. E. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.06.099 · Cited by 72
Pérez, S., & Barceló, . (2008) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2008.09.003 · Cited by 71
Sun, L., Xin, L., Peng, Z., Jin, R., Jin, Y., Qian, H., & Fu, Z. (2013) · Environmental Toxicology · doi:10.1002/tox.21867 · Cited by 68
Celis, R., Gámiz, B., Adelino, M. A., Hermosín, M. C., & Cornejo, J. (2012) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2012.11.105 · Cited by 67
Caballo, C., Sicilia, M. D., & Rubio, S. (2014) · Talanta · doi:10.1016/j.talanta.2014.11.016 · Cited by 65
Enantioselective biodegradation of fluoxetine by the bacterial strain Labrys portucalensis F11
Moreira, I. S., Ribeiro, A. R., Afonso, C., Tiritan, M. E., & Castro, P. M. L. (2014) · Chemosphere · doi:10.1016/j.chemosphere.2014.03.022 · Cited by 63
Berninger, J. P., LaLone, C. A., Villeneuve, D. L., & Ankley, G. T. (2015) · Environmental Toxicology and Chemistry · doi:10.1002/etc.2965 · Cited by 60
Distinct Enantiomeric Signals of Ibuprofen and Naproxen in Treated Wastewater and Sewer Overflow
Khan, S. J., Wang, L., Hashim, N. H., & McDonald, J. A. (2013) · Chirality · doi:10.1002/chir.22258 · Cited by 60
Camacho‐Muñoz, D., & Kasprzyk‐Hordern, B. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9075-6 · Cited by 59
Evans, S. E., & Kasprzyk‐Hordern, B. (2014) · Trends in Environmental Analytical Chemistry · doi:10.1016/j.teac.2013.11.005 · Cited by 59
Enantiospecific fate of ibuprofen, ketoprofen and naproxen in a laboratory-scale membrane bioreactor
Hashim, N. H., Nghiem, L. D., Stuetz, R. M., & Khan, S. J. (2011) · Water Research · doi:10.1016/j.watres.2011.09.020 · Cited by 56
Gámiz, B., Facenda, G., & Celis, R. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.03.052 · Cited by 52
Hashim, N. H., Shafie, S., & Khan, S. J. (2010) · Environmental Technology · doi:10.1080/09593331003728022 · Cited by 49
Barclay, V. K. H., Tyrefors, N. L., Johansson, I. M., & Pettersson, C. E. (2011) · Journal of Chromatography A · doi:10.1016/j.chroma.2011.06.024 · Cited by 48
Chiral signature of venlafaxine as a marker of biological attenuation processes
Li, Z., Góméz, E., Fenet, H., & Chirón, S. (2012) · Chemosphere · doi:10.1016/j.chemosphere.2012.10.033 · Cited by 47
Ardakani, Y. H., Mehvar, R., Foroumadi, A., & Rouini, M. R. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.01.038 · Cited by 45
Stereoisomeric profiling of drugs of abuse and pharmaceuticals in wastewaters of Valencia (Spain)
Vázquez-Roig, P., Kasprzyk‐Hordern, B., Blasco, C., et al. (2014) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2014.06.098 · Cited by 45
Desai, M. J., & Armstrong, D. W. (2004) · Journal of Chromatography A · doi:10.1016/j.chroma.2004.02.057 · Cited by 42
Occurrence and behavior of the chiral anti-inflammatory drug naproxen in an aquatic environment
Suzuki, T., Kosugi, Y., Hosaka, M., Nishimura, T., & Nakae, D. (2014) · Environmental Toxicology and Chemistry · doi:10.1002/etc.2741 · Cited by 42
Expert QSAR system for predicting the bioconcentration factor under the REACH regulation
Grisoni, F., Consonni, V., Vighi, M., Villa, S., & Todeschini, R. (2016) · Environmental Research · doi:10.1016/j.envres.2016.04.032 · Cited by 28
Environmental Fate of Chiral Pharmaceuticals: Determination, Degradation and Toxicity
Ribeiro, A. R., Castro, P. M. L., & Tiritan, M. E. (2011) · Environmental chemistry for a sustainable world · doi:10.1007/978-94-007-2439-6_1 · Cited by 27
Celis, R., Gámiz, B., Facenda, G., & Hermosín, M. C. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2015.07.059 · Cited by 27
Chiral resolution of clenbuterol, cimaterol, and mabuterol on Chirobiotic V, T, and TAG columns
Aboul-Enein, H. Y., & Ali, I. (2002) · Journal of Separation Science · doi:10.1002/1615-9314(20020901)25:13<851::aid-jssc851>3.0.co;2-m · Cited by 27
The effect of humic acid and ash on enantiomeric fraction change of chiral pollutants
Oravec, M., Šimek, Z., & Holoubek, I. (2010) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2010.01.064 · Cited by 26
Sanganyado, E., Lu, Z., & Gan, J. J. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.09.054 · Cited by 20
Self-citationBiologically Mediated Chiral Inversion of Emerging Contaminants
Khan, S. J. (2014) · doi:10.1002/9781118339558.ch08 · Cited by 13
Chirality as an Environmental Forensics Tool
Wong, C. S., & Warner, N. A. (2009) · Wiley eBooks · doi:10.1002/9780470684122.ch4 · Cited by 12
Pharmaceuticals and Personal‐Care Products
Treadgold, J. W., Liu, Q.-T., Plant, J. A., & Voulvoulis, N. (2011) · Wiley eBooks · doi:10.1002/9781119950127.ch8 · Cited by 10
(1997) · doi:10.1002/(sici)1520-636x(1997)9:2<99::aid-chir3>3.0.co;2-b
Cited by
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C. U., & Mohan, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00299 · Cited by 2,654
Contribution of Organofluorine Compounds to Pharmaceuticals
Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c00830 · Cited by 1,944
Current Contributions of Organofluorine Compounds to the Agrochemical Industry
Ogawa, Y., Tokunaga, E., Kobayashi, O., Hirai, K., & Shibata, N. (2020) · iScience · doi:10.1016/j.isci.2020.101467 · Cited by 1,253
Antibiotic resistance in drinking water systems: Occurrence, removal, and human health risks
Sanganyado, E., & Gwenzi, W. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2019.03.162 · Cited by 504
Self-citation
Metadata
- Authors
- Sanganyado, E., Lu, Z., Fu, Q., Schlenk, D., & Gan, J.
- Venue
- Water Research
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 124
- Pages
- 527-542
- ISSN
- 0043-1354 (ISSN-L)
- OpenAlex
- W2742820964
- Cited by
- 292
- References
- 99
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.